Meaning-Centered Coping Skills Training for Cancer Pain
(MCPC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people with advanced cancer manage pain. It focuses on teaching skills like guided imagery and activity pacing to improve pain coping. Called Meaning-Centered Pain Coping Skills Training, this method will be compared to standard care. Participants will be randomly assigned to either this new method or standard care, with progress tracked over 12 weeks. Individuals with stage IV solid tumor cancer, experiencing pain that affects daily life, and who can speak and read English, might be eligible to join. As an unphased trial, this study offers a unique opportunity to explore innovative pain management techniques that could enhance quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a psychosocial intervention, so it's likely you can continue your medications, but you should confirm with the trial organizers.
What prior data suggests that Meaning-Centered Pain Coping Skills Training is safe?
Research shows that Meaning-Centered Pain Coping Skills Training (MCPC) safely manages cancer pain. The risks are minimal and mainly involve common concerns in similar programs, such as maintaining privacy. This treatment includes video sessions that teach pain management techniques like mental imagery and activity pacing. Studies have found that patients often feel better after participating in MCPC. Overall, evidence suggests this approach is well-tolerated and lacks significant side effects.12345
Why are researchers excited about this trial?
Researchers are excited about Meaning-Centered Pain Coping Skills Training because it offers a new approach to managing cancer pain through cognitive and behavioral techniques. Unlike typical pain management treatments, which often rely on medications like opioids, this method uses guided imagery and activity pacing to help patients gain control over their pain. By delivering these sessions via videoconference, it also makes support more accessible to patients, regardless of location. This innovative approach has the potential to empower patients by providing them with practical skills to handle pain, potentially reducing their dependence on medications.
What evidence suggests that Meaning-Centered Pain Coping Skills Training is effective for managing cancer pain?
Research has shown that Meaning-Centered Pain Coping Skills Training (MCPC), which participants in this trial may receive, is a promising method for managing pain in patients with advanced cancer. This approach addresses not only physical pain but also mental, social, and spiritual aspects. Early studies have found MCPC easy to use and engaging, suggesting it could be a valuable tool for improving pain management. Although further testing is needed to confirm its effectiveness, the initial results are encouraging. This method employs techniques such as guided imagery and pacing activities to help patients better manage their pain.12367
Who Is on the Research Team?
Joseph G Winger, PhD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 with advanced solid tumor cancer and pain. They must have a performance status that allows daily activity (ECOG ≤2) and have experienced pain recently. It's not for those with significant cognitive issues, untreated serious mental illness, brain cancer, previous similar therapy experience, or in hospice care.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Meaning-Centered Pain Coping Skills Training (MCPC) through four weekly videoconference sessions focusing on cognitive-behavioral skills for managing pain.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 8-week and 12-week follow-ups.
What Are the Treatments Tested in This Trial?
Interventions
- Meaning-Centered Pain Coping Skills Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
American Cancer Society, Inc.
Collaborator